Invention Grant
- Patent Title: Apoptosis signal-regulating kinase inhibitor
- Patent Title (中): 细胞凋亡信号调节激酶抑制剂
-
Application No.: US14254342Application Date: 2014-04-16
-
Publication No.: US09254284B2Publication Date: 2016-02-09
- Inventor: Gregory Notte
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D213/56 ; A61K31/4439 ; C07D401/14 ; C07D233/56 ; C07D401/04
Abstract:
The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Public/Granted literature
- US20140228411A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR Public/Granted day:2014-08-14
Information query
